| Date Filed | Type | Description |
| 06/09/2023 |
4
| Rubinstein Linda M (CFO) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Bought 100,000 shares
@ $1.4549, valued at
$145.5k
|
|
| 03/17/2023 |
4
| Riley Brigit (Chief Scientific Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Sold 7,299 shares
@ $0.7816, valued at
$5.7k
|
|
| 03/17/2023 |
4
| Soparkar Peter (COO) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Sold 13,360 shares
@ $0.7816, valued at
$10.4k
|
|
| 03/17/2023 |
4
| Fischer Laurent (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Sold 41,239 shares
@ $0.7816, valued at
$32.2k
|
|
| 12/15/2022 |
3
| Rubinstein Linda M (CFO) has filed a Form 3 on Adverum Biotechnologies, Inc. |
| 09/21/2022 |
4
| Beckman Richard (Chief Medical Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Sold 4,272 shares
@ $1.0697, valued at
$4.6k
|
|
| 09/21/2022 |
4
| Seyedkazemi Setareh (Chief Development Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Sold 6,058 shares
@ $1.0696, valued at
$6.5k
|
|
| 09/21/2022 |
4
| Soparkar Peter (See Remarks section) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Sold 13,305 shares
@ $1.0697, valued at
$14.2k
|
|
| 09/21/2022 |
4
| Riley Brigit (Chief Scientific Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Sold 7,266 shares
@ $1.0697, valued at
$7.8k
|
|
| 09/21/2022 |
4
| Fischer Laurent (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Sold 41,082 shares
@ $1.0696, valued at
$43.9k
|
|
| 09/21/2022 |
4/A
| Beckman Richard (Chief Medical Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 33,333 shares
@ $0 |
|
| 09/16/2022 |
4
| Beckman Richard (Chief Medical Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 25,000 shares
@ $0 |
|
| 09/16/2022 |
4
| Seyedkazemi Setareh (Chief Development Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 33,333 shares
@ $0 |
|
| 09/16/2022 |
4
| Riley Brigit (Chief Scientific Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 95,931 options to buy
@ $1.09, valued at
$104.6k
Granted 68,482 options to buy
@ $1.09, valued at
$74.6k
|
|
| 09/16/2022 |
4
| Rakow John (SVP, Genl Counsel, Acting CFO) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 42,813 options to buy
@ $1.09, valued at
$46.7k
Granted 75,257 options to buy
@ $1.09, valued at
$82k
|
|
| 09/16/2022 |
4
| Soparkar Peter (See Remarks section) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 163,847 options to buy
@ $1.09, valued at
$178.6k
Granted 230,924 options to buy
@ $1.09, valued at
$251.7k
|
|
| 09/16/2022 |
4
| Fischer Laurent (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 675,022 options to buy
@ $1.09, valued at
$735.8k
Granted 584,978 options to buy
@ $1.09, valued at
$637.6k
|
|
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/07/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/24/2022 |
4
| Seyedkazemi Setareh (Chief Development Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Bought 20,000 shares
@ $0.84, valued at
$16.8k
|
|
| 05/19/2022 |
4
| Beckman Richard (Chief Medical Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Bought 10,000 shares
@ $0.8228, valued at
$8.2k
|
|
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| D'Souza Rupert (CFO) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Bought 10,000 shares
@ $0.8585, valued at
$8.6k
Bought 10,000 shares
@ $0.8272, valued at
$8.3k
|
|
| 04/22/2022 |
4
| Fischer Laurent (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Bought 25,000 shares
@ $1.112, valued at
$27.8k
|
|
| 04/20/2022 |
4
| Soparkar Peter (See Remarks section) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Bought 175 shares
@ $1.1373, valued at
$199
Bought 21,750 shares
@ $1.14, valued at
$24.8k
|
|
| 03/18/2022 |
4
| Hong Soo (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 80,000 options to buy
@ $1.35, valued at
$108k
|
|
| 03/18/2022 |
3
| Hong Soo (Director) has filed a Form 3 on Adverum Biotechnologies, Inc. |
|